Rieter Holding AG
SIX:RIEN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Rieter Holding AG
SIX:RIEN
|
CH |
|
C
|
Clinuvel Pharmaceuticals Ltd
XMUN:UR9
|
AU |
|
Kamada Ltd
NASDAQ:KMDA
|
IL |
Wall St Price Targets
RIEN Price Targets Summary
Rieter Holding AG
According to Wall Street analysts, the average 1-year price target for
RIEN is 3.62 CHF with a low forecast of 3.13 CHF and a high forecast of 4.2 CHF.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is RIEN's stock price target?
Price Target
3.62
CHF
According to Wall Street analysts, the average 1-year price target for
RIEN is 3.62 CHF with a low forecast of 3.13 CHF and a high forecast of 4.2 CHF.
What is the Revenue forecast for Rieter Holding AG?
Projected CAGR
13%
Over the last 13 years, the compound annual growth rate for Revenue has been -2%. The projected CAGR for the next 8 years is 13%.